Clinical Trial Characteristics of Ophthalmologic Disease

Ophthalmologic conditions currently affect almost 300 million globally and trials which to cure these rare, genetic, age-related, and degenerative afflictions are often difficult to be conducted because of the few choices for clinical centers.

Advantages of Tigermed

Tigermed has established good cooperation with a number of domestic ophthalmology clinical study centers, and has experience in clinical trial management in many ophthalmic fields.

Project Experience

The Ophthalmic products team is managed by 2 project directors and 3 project managers who have an average working experience of 7 years.